Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Clifford, G M; Rickenbach, M; Polesel, J; Dal Maso, L; Steffen, I; Ledergerber, B; Rauch, A; Probst-Hensch, N M; Bouchardy, C; Levi, F; Franceschi, S (2008). Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS, 22(16):2135-2141.

Franceschi, S; Maso, L D; Rickenbach, M; Polesel, J; Hirschel, B; Cavassini, M; Bordoni, A; Elzi, L; Ess, S; Jundt, G; Mueller, N; Clifford, G M; Swiss HIV Cohort Study (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer, 99(5):800-804.

Polesel, J; Clifford, G M; Rickenbach, M; Dal Maso, L; Battegay, M; Bouchardy, C; Furrer, H; Hasse, B; Levi, F; Probst-Hensch, N M; Schmid, P; Franceschi, S (2008). Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, 22(2):301-306.

Franceschi, S; Polesel, J; Rickenbach, M; Dal Maso, L; Probst-Hensch, N M; Fux, C; Cavassini, M; Hasse, B; Kofler, A; Ledergerber, B; Erb, P; Clifford, G M (2006). Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. British Journal of Cancer, 95(11):1598-1602.

Clifford, G M; Polesel, J; Rickenbach, M; Dal Maso, L; Keiser, O; Kofler, A; Rapiti, E; Levi, F; Jundt, G; Fisch, T; Bordoni, A; De Weck, D; Franceschi, S (2005). Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97(6):425-432.

This list was generated on Wed Sep 20 08:59:52 2017 CEST.